<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02404142</url>
  </required_header>
  <id_info>
    <org_study_id>PI14034</org_study_id>
    <nct_id>NCT02404142</nct_id>
  </id_info>
  <brief_title>Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium</brief_title>
  <acronym>GICAC</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Verathon</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, randomized study, the investigators assess the intubation conditions
      during videolaryngoscopy with Glidescope Titanium whether patients receive (curare
      (Atracurium) group) or no (control group) within elective surgery patients with no difficult
      intubation prediction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, randomized study, the investigators assess the intubation conditions
      during videolaryngoscopy with Glidescope Titanium whether patients receive (curare
      (Atracurium)group) or no (control group) within elective surgery patients with no difficult
      intubation prediction. The IDS score assessed by an anesthesiologist from the video-recording
      is the primary outcome. All general anesthesias are standardized using Target Control
      Infusion of propofol and sufentanil. The investigators also compare IDS scores as assessed by
      intubators, time for tracheal intubation, and laryngeal morbidity in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 20, 2015</start_date>
  <completion_date type="Actual">August 5, 2016</completion_date>
  <primary_completion_date type="Actual">April 5, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IDS score video-assessed as described by Adnet et al. Measurement will be made by 2 experts anesthesiologists for centralized reading</measure>
    <time_frame>Assessment will be done at the end of the inclusions period (9 months)</time_frame>
    <description>Number of IDS scores &lt;2 are compared</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IDS score assesed by the intubator anesthesiologist</measure>
    <time_frame>3 days post intubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Tracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Control group (saline isotonic solution)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline isotonic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curar (Atracurium) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curar (Atracurium)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curare (Atracurium)</intervention_name>
    <description>Curare (Atracurium) versus saline isotonic solution for tracheal intubation</description>
    <arm_group_label>Curar (Atracurium) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline isotonic solution</intervention_name>
    <arm_group_label>Control group (saline isotonic solution)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective Surgery Adult Patients

          -  no difficult intubation prediction

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2015</study_first_submitted>
  <study_first_submitted_qc>March 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2015</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Trachel intubation</keyword>
  <keyword>IDS score</keyword>
  <keyword>Videoaryngoscopy</keyword>
  <keyword>Glidescope® Titanium®</keyword>
  <keyword>NMBA</keyword>
  <keyword>Curare (Atracurium)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Atracurium</mesh_term>
    <mesh_term>Curare</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

